In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), which produce the SARS-CoV-2 spike protein to activate potent B and ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, there is no vaccine approved to simultaneously protect against both viral ...

Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play ...

Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...

The Vaccine and Infectious Disease Organization out of the University of Saskatchewan has received a $24 million grant to aid ...

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...